文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

作者信息

de Alava E, Kawai A, Healey J H, Fligman I, Meyers P A, Huvos A G, Gerald W L, Jhanwar S C, Argani P, Antonescu C R, Pardo-Mindan F J, Ginsberg J, Womer R, Lawlor E R, Wunder J, Andrulis I, Sorensen P H, Barr F G, Ladanyi M

机构信息

Clinica Universitaria de Navarra, Pamplona, Spain.

出版信息

J Clin Oncol. 1998 Apr;16(4):1248-55. doi: 10.1200/JCO.1998.16.4.1248.


DOI:10.1200/JCO.1998.16.4.1248
PMID:9552022
Abstract

PURPOSE: More than 90% of Ewing's sarcomas (ES) contain a fusion of the EWS and FLI1 genes, due to the t(11;22)(q24;q12) translocation. At the molecular level, the EWS-FLI1 rearrangements show great diversity. Specifically, many different combinations of exons from EWS and FLI1 encode in-frame fusion transcripts and result in differences in the length and composition of the chimeric protein, which functions as an oncogenic aberrant transcription factor. In the most common fusion type (type 1), EWS exon 7 is linked in frame with exon 6 of FLI1. As the fundamental pathogenetic lesion in ES, the molecular heterogeneity of these fusion transcripts may have functional and clinical significance. PATIENTS AND METHODS: We performed a clinical and pathologic analysis of 112 patients with ES in which EWS-FLI1 fusion transcripts were identified by reverse-transcriptase polymerase chain reaction (RT-PCR). Adequate treatment and follow-up data were available in 99 patients treated with curative intent. Median follow-up in these 99 patients was 26 months (range, 1 to 140 months). Univariate and multivariate survival analyses were performed that included other prognostic factors, such as age, tumor location, size, and stage. RESULTS: Among the 99 patients suitable for survival analysis, the tumors in 64 patients contained the type 1 fusion and in 35 patients contained less common fusion types. Stage at presentation was localized in 74 patients and metastatic in 25. Metastases (relative risk [RR] = 2.6; P = .008), and type 1 EWS-FLI1 fusion (RR = 0.37; P = .014) were, respectively, independent negative and positive prognostic factors for overall survival by multivariate analysis. Among 74 patients with localized tumors, the type 1 EWS-FLI1 fusion was also a significant positive predictor of overall survival (RR = 0.32; P = .034) by multivariate analysis. CONCLUSION: EWS-FLI1 fusion type appears to be prognostically relevant in ES, independent of tumor site, stage, and size. Further studies are needed to clarify the biologic basis of this phenomenon.

摘要

相似文献

[1]
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

J Clin Oncol. 1998-4

[2]
Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.

Klin Padiatr. 2004

[3]
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.

J Clin Oncol. 2010-3-22

[4]
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.

Cancer Res. 1999-4-1

[5]
EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.

J Clin Oncol. 1999-6

[6]
Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

J Clin Oncol. 1996-4

[7]
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

J Clin Oncol. 2010-3-22

[8]
EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma.

Eur J Cancer. 1997-2

[9]
Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type.

Lab Invest. 2000-12

[10]
[Detection of EWS-FLI1 fusion transcript in Ewing's sarcoma/peripheral primitive neuroectodermal tumors by one-step RT-PCR using paraffin-embedded tissues].

Zhonghua Bing Li Xue Za Zhi. 2004-8

引用本文的文献

[1]
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.

medRxiv. 2025-1-20

[2]
A rare case report of omental synovial sarcoma complicated hemoperitoneum and literature review.

World J Surg Oncol. 2024-11-14

[3]
Pediatric Extra-skeletal Sinonasal Ewing's Sarcoma: Report of Two Cases with Literature Review.

Indian J Surg Oncol. 2024-9

[4]
Human EWS-FLI protein levels and neomorphic functions show a complex, function-specific dose-response relationship in .

Open Biol. 2024-7

[5]
EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion.

bioRxiv. 2024-6-25

[6]
Primary mediastinal Ewing's sarcoma presenting with sudden and severe chest pain: a case report.

Front Oncol. 2024-1-12

[7]
Large Pelvic Mass in a Female Adolescent: Atypical Presentation and Successful Treatment of Extraskeletal Ewing Sarcoma.

Healthcare (Basel). 2023-5-10

[8]
Renal primitive neuroectodermal tumor: A rare case with a good prognosis.

Front Surg. 2023-4-19

[9]
Fuzzy Drug Targets: Disordered Proteins in the Drug-Discovery Realm.

ACS Omega. 2023-3-8

[10]
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.

NPJ Precis Oncol. 2022-9-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索